KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Payables (2016 - 2025)

Cvs Health (CVS) has disclosed Payables for 17 consecutive years, with $17.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables fell 2.05% year-over-year to $17.6 billion, compared with a TTM value of $17.6 billion through Dec 2025, down 2.05%, and an annual FY2025 reading of $17.6 billion, down 2.05% over the prior year.
  • Payables was $17.6 billion for Q4 2025 at Cvs Health, down from $19.0 billion in the prior quarter.
  • Across five years, Payables topped out at $20.3 billion in Q2 2025 and bottomed at $11.1 billion in Q2 2021.
  • Average Payables over 5 years is $15.0 billion, with a median of $14.6 billion recorded in 2022.
  • Peak annual rise in Payables hit 40.8% in 2025, while the deepest fall reached 2.05% in 2025.
  • Year by year, Payables stood at $12.5 billion in 2021, then increased by 18.29% to $14.8 billion in 2022, then grew by 1.75% to $15.1 billion in 2023, then grew by 19.3% to $18.0 billion in 2024, then fell by 2.05% to $17.6 billion in 2025.
  • Business Quant data shows Payables for CVS at $17.6 billion in Q4 2025, $19.0 billion in Q3 2025, and $20.3 billion in Q2 2025.